Overview

Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)

Status:
Recruiting

Trial end date:
2023-01-30

Target enrollment:

Participant gender:

Summary

Evaluate the safety and effectiveness of OC-01 (varenicline) nasal spray among subjects suffering from dry eye following photorefractive keratectomy (PRK)

Phase:

Phase 3

Details

Lead Sponsor:

Brandon Baartman

Treatments:

Varenicline